// App-Quantinova.ai

3603 : Targeting the Mammalian Mitochondrial Clpp (mClpP) As a Novel Therapeutic Strategy for Acute Myeloid Leukemia

Researchers

Presenter

  • Zezhou Wang

Principal Investigators

  • Rachel Mattson

  • Walid A. Houry

  • Aaron D. Schimmer

  • Rose Hurren

  • Fengshu Lin

  • Marcela Gronda

  • Neil Maclean

  • Methvin Isaac

  • Elisa Leung

  • Mohan Babu

  • Mahadeo A. Sukhai

Medical Centers

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Rhabdomyosarcoma

Biomarkers

  • Annexin V

Drug/Treatment

  • Filgrastim

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim